Go AS - Search Results

1

Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.

Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. Singer DE, et al. Among authors: go as. Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):297-304. doi: 10.1161/CIRCOUTCOMES.108.830232. Epub 2009 Jun 9. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031854 Free PMC article.

2

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Go AS, et al. Ann Intern Med. 1999 Dec 21;131(12):927-34. doi: 10.7326/0003-4819-131-12-199912210-00004. Ann Intern Med. 1999. PMID: 10610643

3

Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, Selby JV, Singer DE. Go AS, et al. Circulation. 2000 Jul 4;102(1):11-3. doi: 10.1161/01.cir.102.1.11. Circulation. 2000. PMID: 10880408

4

Antithrombotic therapy in atrial fibrillation.

Singer DE, Go AS. Singer DE, et al. Among authors: go as. Clin Geriatr Med. 2001 Feb;17(1):131-47. doi: 10.1016/s0749-0690(05)70110-5. Clin Geriatr Med. 2001. PMID: 11270126 Review.

5

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Go AS, et al. JAMA. 2001 May 9;285(18):2370-5. doi: 10.1001/jama.285.18.2370. JAMA. 2001. PMID: 11343485

6

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Hylek EM, et al. Among authors: go as. Ann Intern Med. 2001 Sep 18;135(6):393-400. doi: 10.7326/0003-4819-135-6-200109180-00008. Ann Intern Med. 2001. PMID: 11560452

7

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE. Hylek EM, et al. Among authors: go as. N Engl J Med. 2003 Sep 11;349(11):1019-26. doi: 10.1056/NEJMoa022913. N Engl J Med. 2003. PMID: 12968085 Free article.

8

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Go AS, Reed GL, Hylek EM, Phillips KA, Liu L, Henault LE, Selby JV, Singer DE. Go AS, et al. J Thromb Thrombolysis. 2003 Feb;15(1):41-6. doi: 10.1023/a:1026192301848. J Thromb Thrombolysis. 2003. PMID: 14574075

9

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE. Go AS, et al. JAMA. 2003 Nov 26;290(20):2685-92. doi: 10.1001/jama.290.20.2685. JAMA. 2003. PMID: 14645310

10

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Singer DE, et al. Among authors: go as. Chest. 2004 Sep;126(3 Suppl):429S-456S. doi: 10.1378/chest.126.3_suppl.429S. Chest. 2004. PMID: 15383480 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters